Global Blood Therapeutics Inc (NASDAQ:GBT)
| 27.36 Delayed Data As of May 20 |  +0.52 / +1.94%Today’s Change | 22.67 Today|||52-Week Range 41.73 | -6.53% Year-to-Date |
Latest GBT News | Press Releases
| EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC Buys 4, Sells 1 in 1st Quarter May 18 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 26.84 |
| Today’s open | 27.23 |
| Day’s range | 26.06 - 27.23 |
| Volume | 35,687 |
| Average volume (3 months) | 1,236,215 |
| Market cap | $1.5B |
Data as of 4:04pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | -19.27% |
| Earnings growth (this year) | +3.96% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +57.31% |
| P/E ratio | NM |
| Price/Sales | 9.46 |
| Price/Book | 7.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IRWDIronwood Pharmaceuti... | -0.07 | -0.61% |
| TPTXTurning Point Therap... | +1.43 | +4.04% |
| ---- | ||
| FHAIMicroalliance Group ... | -0.25 | -7.58% |
Data as of 4:04pm ET, 05/20/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | -$1.19 |
| Annual revenue (last year) | $194.7M |
| Annual profit (last year) | -$303.1M |
| Net profit margin | -155.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
